A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy

L Strigari, M Benassi, G Arcangeli, V Bruzzaniti… - International Journal of …, 2010 - Elsevier
PURPOSE: To investigate the predictors of incidence and duration of xerostomia (XT) based
on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole …
被引用次数：37 相关文章

[引用][C] A NOVEL DOSE CONSTRAINT TO REDUCE XEROSTOMIA IN HEAD-AND-NECK CANCER PATIENTS TREATED WITH INTENSITY-MODULATED …

L STRIGARI, M BENASSI… - … journal of radiation …, 2010 - pascal-francis.inist.fr
A NOVEL DOSE CONSTRAINT TO REDUCE XEROSTOMIA IN HEAD-AND-NECK CANCER
PATIENTS TREATED WITH INTENSITY-MODULATED RADIOTHERAPY CNRS Inist …

A Novel Dose Constraint to Reduce Xerostomia in Head-and-Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

L Strigari, M Benassi, G Arcangeli… - International Journal of …, 2010 - inis.iaea.org
[en] Purpose: To investigate the predictors of incidence and duration of xerostomia (XT)
based on parotid glands (PG), submandibular glands (SMG), and both glands taken as a …
[PDF] academia.edu

[PDF][PDF] A NOVEL DOSE CONSTRAINT TO REDUCE XEROSTOMIA IN HEAD-AND-NECK CANCER PATIENTS TREATED WITH INTENSITY-MODULATED …

V BRUZZANITI, G GIOVINAZZO… - Int. J. Radiation Oncology …, 2010 - academia.edu
Purpose: To investigate the predictors of incidence and duration of xerostomia (XT) based
on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole …

A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy.

L Strigari, M Benassi, G Arcangeli… - … Journal of Radiation …, 2010 - europepmc.org
A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with
intensity-modulated radiotherapy. - Abstract - Europe PMC Sign in | Create an account https://orcid.org …

A Novel Dose Constraint to Reduce Xerostomia in Head-and-Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

L Strigari, M Benassi, G Arcangeli, V Bruzzaniti… - International Journal of …, 2010 - infona.pl
To investigate the predictors of incidence and duration of xerostomia (XT) based on parotid
glands (PG), submandibular glands (SMG), and both glands taken as a whole organ (TG) in …

A Novel Dose Constraint to Reduce Xerostomia in Head-and-Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

L Strigari, M Benassi, G Arcangeli, V Bruzzaniti… - International Journal of …, 2010 - osti.gov
Purpose: To investigate the predictors of incidence and duration of xerostomia (XT) based
on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole …

A Novel Dose Constraint to Reduce Xerostomia in Head-and-Neck Cancer Patients Treated With Intensity-Modulated Radiotherapy

L Strigari, M Benassi, G Arcangeli… - International Journal of …, 2010 - redjournal.org
Purpose To investigate the predictors of incidence and duration of xerostomia (XT) based on
parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole organ …

A novel dose constraint to reduce xerostomia in head-and-neck cancer patients treated with intensity-modulated radiotherapy

L Strigari, M Benassi, G Arcangeli… - … journal of radiation …, 2010 - pubmed.ncbi.nlm.nih.gov
Purpose To investigate the predictors of incidence and duration of xerostomia (XT) based on
parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole organ …
[PDF] academia.edu

[PDF][PDF] A NOVEL DOSE CONSTRAINT TO REDUCE XEROSTOMIA IN HEAD-AND-NECK CANCER PATIENTS TREATED WITH INTENSITY-MODULATED …

V BRUZZANITI, G GIOVINAZZO… - Int. J. Radiation Oncology …, 2010 - academia.edu
Purpose: To investigate the predictors of incidence and duration of xerostomia (XT) based
on parotid glands (PG), submandibular glands (SMG), and both glands taken as a whole …